313 related articles for article (PubMed ID: 15450253)
1. Oncostatin M: a pleiotropic cytokine in the central nervous system.
Chen SH; Benveniste EN
Cytokine Growth Factor Rev; 2004 Oct; 15(5):379-91. PubMed ID: 15450253
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
Godoy-Tundidor S; Cavarretta IT; Fuchs D; Fiechtl M; Steiner H; Friedbichler K; Bartsch G; Hobisch A; Culig Z
Prostate; 2005 Jul; 64(2):209-16. PubMed ID: 15712220
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M, a multifunctional cytokine.
Tanaka M; Miyajima A
Rev Physiol Biochem Pharmacol; 2003; 149():39-52. PubMed ID: 12811586
[TBL] [Abstract][Full Text] [Related]
4. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
[TBL] [Abstract][Full Text] [Related]
5. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
Underhill-Day N; Heath JK
Cancer Res; 2006 Nov; 66(22):10891-901. PubMed ID: 17108126
[TBL] [Abstract][Full Text] [Related]
6. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
[TBL] [Abstract][Full Text] [Related]
7. Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
Heinrich PC; Behrmann I; Haan S; Hermanns HM; Müller-Newen G; Schaper F
Biochem J; 2003 Aug; 374(Pt 1):1-20. PubMed ID: 12773095
[TBL] [Abstract][Full Text] [Related]
8. Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells.
Repovic P; Fears CY; Gladson CL; Benveniste EN
Oncogene; 2003 Nov; 22(50):8117-24. PubMed ID: 14603252
[TBL] [Abstract][Full Text] [Related]
9. Up-regulated phosphorylation of signal transducer and activator of transcription 3 and cyclic AMP-responsive element binding protein by peripheral inflammation in primary afferent neurons possibly through oncostatin M receptor.
Tamura S; Morikawa Y; Senba E
Neuroscience; 2005; 133(3):797-806. PubMed ID: 15893881
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
[TBL] [Abstract][Full Text] [Related]
11. Specificity of signaling by hematopoietic cytokine receptors: instructive versus permissive effects.
Skoda RC
J Recept Signal Transduct Res; 1999; 19(1-4):741-72. PubMed ID: 10071797
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M induces an acute phase response but does not modulate the growth or maturation-status of liver progenitor (oval) cells in culture.
Matthews VB; Knight B; Tirnitz-Parker JE; Boon J; Olynyk JK; Yeoh GC
Exp Cell Res; 2005 May; 306(1):252-63. PubMed ID: 15878349
[TBL] [Abstract][Full Text] [Related]
13. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
Hintzen C; Quaiser S; Pap T; Heinrich PC; Hermanns HM
Arthritis Rheum; 2009 Jul; 60(7):1932-43. PubMed ID: 19565514
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38.
Van Wagoner NJ; Choi C; Repovic P; Benveniste EN
J Neurochem; 2000 Aug; 75(2):563-75. PubMed ID: 10899931
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M induced alpha1-antitrypsin (AAT) gene expression in Hep G2 cells is mediated by a 3' enhancer.
Morgan K; Marsters P; Morley S; van Gent D; Hejazi A; Backx M; Thorpe ER; Kalsheker N
Biochem J; 2002 Jul; 365(Pt 2):555-60. PubMed ID: 11936950
[TBL] [Abstract][Full Text] [Related]
16. Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M.
Hsu MP; Frausto R; Rose-John S; Campbell IL
Glia; 2015 Jan; 63(1):132-41. PubMed ID: 25103368
[TBL] [Abstract][Full Text] [Related]
17. The Jak-STAT pathway stimulated by interleukin 6.
Horvath CM
Sci STKE; 2004 Nov; 2004(260):tr9. PubMed ID: 15561981
[TBL] [Abstract][Full Text] [Related]
18. Intracellular proteins and mechanisms involved in the control of gp130/JAK/STAT cytokine signaling.
Carbia-Nagashima A; Arzt E
IUBMB Life; 2004 Feb; 56(2):83-8. PubMed ID: 15085931
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M signaling in human glioma cell lines.
Krona A; Järnum S; Salford LG; Widegren B; Aman P
Oncol Rep; 2005 May; 13(5):807-11. PubMed ID: 15809742
[TBL] [Abstract][Full Text] [Related]
20. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression.
Korzus E; Nagase H; Rydell R; Travis J
J Biol Chem; 1997 Jan; 272(2):1188-96. PubMed ID: 8995420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]